SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-12-052504
Filing Date
2012-02-10
Accepted
2012-02-10 16:08:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 3 d297119dsc13ga.htm SC 13G/A 36007
2 JOINT FILING AGREEMENT d297119dex991.htm EX-99.1 4008
  Complete submission text file 0001193125-12-052504.txt   41870
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44877 | Film No.: 12592966
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 312-634-9200
COLUMBIA WANGER ASSET MANAGEMENT LLC (Filed by) CIK: 0000908733 (see all company filings)

IRS No.: 043519872 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000